Published in Cancer Res on February 01, 1998
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature (2009) 3.93
Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome. Oncogene (2010) 1.57
Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology. J Mol Diagn (2009) 1.29
Down syndrome and the enteric nervous system. Pediatr Surg Int (2008) 1.07
Constitutional aneuploidy and cancer predisposition. Hum Mol Genet (2009) 1.05
Cancer cells preferentially lose small chromosomes. Int J Cancer (2012) 1.02
Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nat Rev Cancer (2012) 1.01
Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc. PLoS One (2014) 0.88
Survival and morbidity outcomes for very low birth weight infants with Down syndrome. Pediatrics (2010) 0.87
An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model. BMC Dev Biol (2007) 0.85
Tongue carcinoma in an adult Down's syndrome patient: a case report. World J Surg Oncol (2009) 0.79
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours. Mol Cancer (2013) 0.78
Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics. Neural Plast (2012) 0.78
Temporal clustering of neuroblastic tumours in children and young adults from Northern England. Environ Health (2015) 0.75
RCAN1-4 is a thyroid cancer growth and metastasis suppressor. JCI Insight (2017) 0.75
Neonatal tumours. Pediatr Surg Int (2013) 0.75
SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature. Childs Nerv Syst (2016) 0.75
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol (1993) 10.87
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet (1998) 3.91
Contacts between adults as evidence for an infective origin of childhood leukaemia: an explanation for the excess near nuclear establishments in west Berkshire? Br J Cancer (1991) 3.44
Cancer in Cumbria and in the vicinity of the Sellafield nuclear installation, 1963-90. BMJ (1993) 2.94
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A (1995) 2.89
Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I. Scand J Gastroenterol (1999) 2.89
Neuroblastoma in Europe: differences in the pattern of disease in the UK. SENSE. Study group for the Evaluation of Neuroblastoma Screening in Europe. Lancet (1998) 2.77
Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol (2009) 2.73
Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med (1996) 2.66
The international incidence of childhood cancer. Int J Cancer (1988) 2.53
The inter-regional epidemiological study of childhood cancer (IRESCC): a case control study of aetiological factors in leukaemia and lymphoma. Arch Dis Child (1987) 2.49
Childhood leukaemia and non-Hodgkin's lymphoma near large rural construction sites, with a comparison with Sellafield nuclear site. BMJ (1995) 2.41
Metabolic activity and clinical features of primary ganglioneuromas. Cancer (2001) 2.41
Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother (2000) 2.25
Intramuscular vitamin K and childhood cancer. BMJ (1992) 2.13
Trends in childhood leukaemia in Britain 1968-1978. Br J Cancer (1982) 2.04
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol (1993) 1.88
Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med (1998) 1.87
MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. Eur J Cancer (2004) 1.85
The international classification of childhood cancer. Int J Cancer (1996) 1.84
Treatment of Langerhans-cell histiocytosis in children. Experience at the Children's Hospital of Nancy. J Bone Joint Surg Am (1994) 1.84
Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. Br Med J (1979) 1.84
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet (2006) 1.83
Rifampin and rifabutin resistance mechanism in Helicobacter pylori. Antimicrob Agents Chemother (1999) 1.80
Descriptive epidemiology of childhood leukaemia and lymphoma in Great Britain. Leuk Res (1985) 1.79
Childhood NHL in Switzerland: incidence and survival of 120 study and 42 non-study patients. Med Pediatr Oncol (1995) 1.77
Case-control studies for the evaluation of screening. J Chronic Dis (1986) 1.76
The multitude and diversity of environmental carcinogens. Environ Res (2007) 1.73
Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet (1997) 1.69
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol (2003) 1.67
A new calculation of the carcinogenic risk of obstetric X-raying. Stat Med (1988) 1.66
[An exceptional variety of medulloblastoma: melanotic medulloblastoma]. Ann Pathol (1997) 1.65
The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol (2004) 1.65
Childhood leukaemia and socioeconomic status in England and Wales 1976-2005: evidence of higher incidence in relatively affluent communities persists over time. Br J Cancer (2011) 1.63
Trends in incidence of brain and central nervous system tumors in Norway, 1970-1999. Neuroepidemiology (2004) 1.62
Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J Clin Microbiol (1996) 1.62
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. J Clin Oncol (1997) 1.59
Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging. Obstet Gynecol (1992) 1.57
Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood (1992) 1.55
Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet (1993) 1.55
Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer (2002) 1.53
Spatial attention deficits in humans: a comparison of superior parietal and temporal-parietal junction lesions. Neuropsychology (1998) 1.51
High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant (1992) 1.49
Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature. Eur J Cancer (2004) 1.47
New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatr Oncol (1999) 1.47
Improved survival for childhood acute lymphoblastic leukemia: possible effect of protocol compliance. Pediatr Hematol Oncol (1988) 1.46
Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Br J Haematol (1999) 1.46
Vincristine revisited. Crit Rev Oncol Hematol (1999) 1.46
Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth. Br J Cancer (2010) 1.45
Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet (1995) 1.45
Masses of exotic calcium isotopes pin down nuclear forces. Nature (2013) 1.45
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis (2000) 1.45
Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol (2001) 1.45
Assessment of fine needle aspiration cytology and histopathology for diagnosing male breast masses. Acta Cytol (1995) 1.44
Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. Eur J Cancer Prev (2004) 1.43
The role of chemotherapy, surgery, and radiotherapy in rhabdomyosarcoma of the orbit. Pediatr Hematol Oncol (1992) 1.42
The epidemiology of neonatal tumours. Report of an international working group. Pediatr Surg Int (2003) 1.42
Retinoblastoma and low level radiation. BMJ (1993) 1.40
Survival after transurethral and transvesical surgery in localized cancer of the prostate, Norway 1957-1981. Cancer (1993) 1.39
[A cavernous haemangioma of the colon as the cause of rectal bleeding in childhood]. Ned Tijdschr Geneeskd (2004) 1.39
[Severe hyperlactacidemia in 2 children treated for malignant tumors. Role of vitamin B1]. Arch Fr Pediatr (1991) 1.39
Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer (2004) 1.39
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification. Br J Cancer (2007) 1.39
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J (2010) 1.38
Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer (2006) 1.38
Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer (1987) 1.37
Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet (1988) 1.36
Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Oncogene (2007) 1.36
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia (2007) 1.36
Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase. Br J Cancer (2012) 1.35
Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol (1993) 1.34
Congenital diaphragmatic hernia: the hidden mortality. J Pediatr Surg (1978) 1.34
Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Cancer (1999) 1.31
The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer (1997) 1.30
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death Dis (2013) 1.30
Treatment of stage 4s neuroblastoma--report of 10 years' experience of the French Society of Paediatric Oncology (SFOP). Br J Cancer (2003) 1.29
Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer (2004) 1.29
Psychological adaptation and social support of parents of pediatric cancer patients: a prospective longitudinal study. J Pediatr Psychol (2001) 1.28
Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod (2001) 1.28
Use of SSRs for establishing heterotic groups in subtropical maize. Theor Appl Genet (2003) 1.28
Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia (2001) 1.28
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood (1998) 1.28
European health systems and cancer care. Ann Oncol (2003) 1.27
Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res (1995) 1.26
A tumor profile in Down syndrome. Am J Med Genet (1998) 1.26
The health status of adult survivors of cancer in childhood. Eur J Cancer (1998) 1.26
Congenital abnormalities in children with cancer and their relatives: results from a case-control study (IRESCC). Br J Cancer (1993) 1.25
International variations in the incidence of childhood bone tumours. Int J Cancer (1993) 1.25